ID   Mel Ksen
AC   CVCL_B6KT
SY   mel Ksen
DR   Wikidata; Q112129281
RX   CelloPub=CLPUB00680;
RX   Patent=RU2392316;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 713D.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
RX   CelloPub=CLPUB00680;
RA   Mikhailova I.N., Baryshnikov A.Y., Morozova L.F., Burova O.S.,
RA   Shubina I.Z., Kovalevsky D.A., Voronina E.S., Treshalina H.M.,
RA   Lushnikova A.A., Tsyganova I.V., Mazurenko N.N.;
RT   "Human skin melanoma cell lines collection.";
RL   (In) Management of malignant melanoma; None X. (eds.); pp.6.1-6.6; SM Group; Dover (2016).
//
RX   Patent=RU2392316;
RA   Mikhailova I.N., Baryshnikov A.Y., Demidov L.V., Kiselev S.L.,
RA   Burova O.S., Morozova L.F., Baryshnikov K.A.;
RT   "Human melanoma cell line mel Ksen, used for antitumour vaccines
RT   manufacture.";
RL   Patent number RU2392316, 20-Jun-2010.
//